Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Jansen

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Frontiers in Physiology|December 12, 2019
Editorial: Systems Biology and Bioinformatics in Gastroenterology and HepatologyPeter L M Jansen, Kai Breuhahn, Andreas Teufel, et al.
Gastroenterology|January 28, 2012
Fibroblast growth factor 19, an anticholestatic drug produced by human liverPeter L M Jansen, Frank G Schaap, Ulrich H W Beuers
Current Opinion in Investigational Drugs (London, England : 2000)|June 19, 2004
Targeting nitric oxide in the gastrointestinal tractGerard Dijkstra, Harry van Goor, Peter L M Jansen, et al.
Psychopharmacology|May 24, 2000
Selective impairments in the stress response in schizophrenic patientsL M Jansen, C C Gispen-de Wied, R S Kahn
Phytotherapy Research : PTR|August 6, 2014
Effects of five Ayurvedic herbs on locomotor behaviour in a Drosophila melanogaster Parkinson's disease modelR L M Jansen, B Brogan, A J Whitworth, et al.
Hepatology (Baltimore, Md.)|September 3, 2017
Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?Frank G Schaap, Peter L M Jansen, Steven W M Olde Damink
Seminars in Liver Disease|April 28, 2010
Progressive familial intrahepatic cholestasis type 1Coen C Paulusma, Ronald P J Oude Elferink, Peter L M Jansen
Hepatology (Baltimore, Md.)|August 23, 2014
FXR, intestinal FiXeR of hepatocellular carcinoma?Frank G Schaap, Peter L M Jansen, Steven W M Olde Damink
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
The (patho)physiological functions of the MRP familyJohan Renes, Elisabeth G. E. de Vries, Peter L. M. Jansen, et al.
Vox Sanguinis|April 28, 2009
New developments in the antiviral treatment of hepatitis CJ de Bruijne, C J Weegink, P L M Jansen, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Frontiers in Physiology|December 12, 2019
Editorial: Systems Biology and Bioinformatics in Gastroenterology and HepatologyPeter L M Jansen, Kai Breuhahn, Andreas Teufel, et al.
Gastroenterology|January 28, 2012
Fibroblast growth factor 19, an anticholestatic drug produced by human liverPeter L M Jansen, Frank G Schaap, Ulrich H W Beuers
Current Opinion in Investigational Drugs (London, England : 2000)|June 19, 2004
Targeting nitric oxide in the gastrointestinal tractGerard Dijkstra, Harry van Goor, Peter L M Jansen, et al.
Psychopharmacology|May 24, 2000
Selective impairments in the stress response in schizophrenic patientsL M Jansen, C C Gispen-de Wied, R S Kahn
Phytotherapy Research : PTR|August 6, 2014
Effects of five Ayurvedic herbs on locomotor behaviour in a Drosophila melanogaster Parkinson's disease modelR L M Jansen, B Brogan, A J Whitworth, et al.
Hepatology (Baltimore, Md.)|September 3, 2017
Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?Frank G Schaap, Peter L M Jansen, Steven W M Olde Damink
Seminars in Liver Disease|April 28, 2010
Progressive familial intrahepatic cholestasis type 1Coen C Paulusma, Ronald P J Oude Elferink, Peter L M Jansen
Hepatology (Baltimore, Md.)|August 23, 2014
FXR, intestinal FiXeR of hepatocellular carcinoma?Frank G Schaap, Peter L M Jansen, Steven W M Olde Damink
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
The (patho)physiological functions of the MRP familyJohan Renes, Elisabeth G. E. de Vries, Peter L. M. Jansen, et al.
Vox Sanguinis|April 28, 2009
New developments in the antiviral treatment of hepatitis CJ de Bruijne, C J Weegink, P L M Jansen, et al.
Pageof 15